RE: These shares seem cheap16 Feb 2019 16:25
Mike,
Relative to their current revenue they might seem a little cheap but all eyes are on the next Trading update. If revenues can match what the CEO hints at, then way too cheap:
In the traditional small molecule market, the Company has continued to make encouraging progress, evidenced by the signing of seven new partner agreements this year. The Board expects that its existing partnerships, coupled with a number of potential new collaborations, will contribute to very significant growth in this market in 2019 and beyond. In the medium term, management is targeting to get the Company to cash breakeven in this segment alone.